How do international developments affect Switzerland?
Medicine shapes our lives – competition determines where.
Medical progress does not happen in a vacuum. The framework conditions for research and innovation are changing worldwide. Countries are investing strategically, creating better conditions and attracting companies. Switzerland is in global competition for investment, talent and innovation – and must actively safeguard its position.
MFN (Most-Favored-Nation pricing)
International pricing rules influence access
International pricing regulations increasingly influence when and under what conditions new medicines are available in individual markets. For smaller markets such as Switzerland, this can have direct implications for access to innovation.
The future of Switzerland as a location is not a given.
Without competitive framework conditions, Switzerland will lose investment,
innovative capacity – and, in the long term, its economic strength.